about
The treatment of missing data in a large cardiovascular clinical outcomes study.Incomplete data: what you don't know might hurt you.Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trialsSensitivity to censored-at-random assumption in the analysis of time-to-event endpoints.Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial.Using a Counting Process Method to Impute Censored Follow-Up Time Data.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Nonignorable censoring in randomized clinical trials.
@en
Nonignorable censoring in randomized clinical trials.
@nl
type
label
Nonignorable censoring in randomized clinical trials.
@en
Nonignorable censoring in randomized clinical trials.
@nl
prefLabel
Nonignorable censoring in randomized clinical trials.
@en
Nonignorable censoring in randomized clinical trials.
@nl
P2860
P1433
P1476
Nonignorable censoring in randomized clinical trials.
@en
P2093
Daniel F Heitjan
Jiameng Zhang
P2860
P304
P356
10.1191/1740774505CN128OA
P577
2005-01-01T00:00:00Z